L

Lusaris Therapeutics

5 employees

Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$60M

from 1 investors over 1 rounds

L

Lusaris Therapeutics raised $60M on November 2, 2022

Investors: RA Capital Management, L.P.

FAQ